home / stock / ibio / ibio news


IBIO News and Press, iBio Inc. From 11/24/25

Stock Information

Company Name: iBio Inc.
Stock Symbol: IBIO
Market: NYSE
Website: ibioinc.com

Menu

IBIO IBIO Quote IBIO Short IBIO News IBIO Articles IBIO Message Board
Get IBIO Alerts

News, Short Squeeze, Breakout and More Instantly...

IBIO - iBio to Participate in the 8th Annual Evercore Healthcare Conference

SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the 8th Annual Evercore Healthcare Conference, taking place December 2–4, 2025, in Miami. Martin Brenner, ...

IBIO - iBio GAAP EPS of -$0.11, revenue of $0.1M beats by $0.07M

2025-11-13 00:21:53 ET More on iBio iBio prices $50M public offering iBio drops on proposed public offering Seeking Alpha’s Quant Rating on iBio Historical earnings data for iBio Financial information for iBio Read the full article on...

IBIO - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

Strengthened cash position and extended runway into the fourth quarter of fiscal year 2027 after closing underwritten public offering with up to potentially $100 million of total gross proceeds Presented non-human primate data for our potentially first-in-class Activin E antibody,...

IBIO - Expected US Company Earnings on Tuesday, November 11th, 2025

Ensysce Biosciences Inc. (ENSC) is expected to report $-0.85 for Q3 2025 IO Biotech Inc. (IOBT) is expected to report $-0.31 for Q3 2025 Lifeward Ltd. (LFWD) is expected to report $-0.14 for Q3 2025 Life360 Inc. (LIF) is expected to report $0.03 for Q3 2025 Pixelworks Inc. (PXLW) ...

IBIO - Biotech Ignites- Cancer Breakthroughs, Spider Silk Scaling, and Weight-Loss Innovation Fuel Market Momentum

2025-10-30 10:15:17 ET DENVER, Colo., Oct 30, 2025 ( 247marketnews.com )- The biotech and life sciences sector is taking center stage this morning as investors digest a series of breakthroughs spanning oncology, obesity, sustainable materials, and advanced biologics. From Intensity Ther...

IBIO - iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

Previously reported data showed that in a diet-induced obesity mouse model, IBIO-610 drives fat-selective, GLP-1-synergistic weight loss and prevents weight regain following GLP-1 treatment discontinuation New non-human primate data projects a human half-life of up to 100 days, potentiall...

IBIO - iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place November 10–12, 2025 in Boston. M...

IBIO - Worms, Lasers, and Donuts

2025-10-22 15:44:13 ET DENVER, Colo., Oct 22, 2025 ( 247marketnews.com )- As markets enter the final trading stretch of the day, investor attention is shifting to a mix of defense-tech disruptors , digital asset crossovers , and even a surprise move in doughnuts and diagnostic...

IBIO - US Companies Moving the Markets, Morning edition
Tue, Oct 21, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Yueda Digital Holding (YDKG) rose 29.1% to $0.0572 on volume of 513,070,617 shares Beyond Meat Inc. (BYND) rose 50.7% to $2.215 on volume of 395,990,922 shares AiRWA Inc. (YYAI) fell 18.1% to $0.082 on volume of 130,266,829 shares Min...

IBIO - Biotech Booms, as Innovation-Driven Rally Gains Steam

2025-10-21 09:45:45 ET DENVER, Colo., Oct 21, 2025 ( 247marketnews.com )- Markets opened Tuesday with a biotech-heavy tailwind, as investor sentiment surged on a wave of transformational clinical updates, strategic partnerships, and promising regulatory progress across the healthcare an...

Previous 10 Next 10